BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21432144)

  • 1. INK4 Family -A promising target for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer.
    Matsuzaki Y; Sakai T
    Environ Health Prev Med; 2005 Mar; 10(2):72-7. PubMed ID: 21432144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors -Promising agents for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer-.
    Matsuzaki Y; Sowa Y; Hirose T; Yokota T; Sakai T
    Environ Health Prev Med; 2003 Nov; 8(5):157-60. PubMed ID: 21432092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
    Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
    Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
    Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
    J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
    Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J
    FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the INK4 family of genes in prostate carcinomas.
    Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP
    J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG
    Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INK4d-deficient mice are fertile despite testicular atrophy.
    Zindy F; van Deursen J; Grosveld G; Sherr CJ; Roussel MF
    Mol Cell Biol; 2000 Jan; 20(1):372-8. PubMed ID: 10594039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
    Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
    IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor.
    Arcellana-Panlilio MY; Egeler RM; Ujack E; Pinto A; Demetrick DJ; Robbins SM; Coppes MJ
    Genes Chromosomes Cancer; 2000 Sep; 29(1):63-9. PubMed ID: 10918395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of INK4 genes in breast carcinomas.
    Spirin K; Simpson J; Miller C; Koeffler H
    Int J Oncol; 1997 Oct; 11(4):737-44. PubMed ID: 21528268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
    Zindy F; Quelle DE; Roussel MF; Sherr CJ
    Oncogene; 1997 Jul; 15(2):203-11. PubMed ID: 9244355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
    Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
    Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.
    Gagrica S; Brookes S; Anderton E; Rowe J; Peters G
    Cancer Res; 2012 Jan; 72(1):165-75. PubMed ID: 22080569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.
    Kawamata N; Miller CW; Koeffler HP
    Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
    Suzuki T; Narita T; Uchida-Toita M; Yoshida M
    Virology; 1999 Jul; 259(2):384-91. PubMed ID: 10388662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J; Fried M
    Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
    Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF
    Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.
    Forget A; Ayrault O; den Besten W; Kuo ML; Sherr CJ; Roussel MF
    Cell Cycle; 2008 Dec; 7(23):3737-46. PubMed ID: 19029828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.